Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 152 Neoplasm Metastasis 22 Neoplasms 21 Ovarian Neoplasms 12 Sarcoma 10 Pancreatic Neoplasms 9 Squamous Cell Carcinoma of Head and Neck 8 Melanoma 7 Endometrial Neoplasms 7 Colorectal Neoplasms 7 Carcinoma, Non-Small-Cell Lung 7 Prostatic Neoplasms 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Multiple Myeloma 6 Lymphoma, Non-Hodgkin 6 Head and Neck Neoplasms 6 Carcinoma, Renal Cell 6 Recurrence 5 Medulloblastoma 5 Lung Neoplasms 5 Leukemia, Myeloid, Acute 5 Breast Diseases 5 Triple Negative Breast Neoplasms 4 Sarcoma, Ewing 4 Neoplasms by Site 4 Lymphoma, Mantle-Cell 4 Liposarcoma 4 Glioma 4 Glioblastoma 4 Colonic Neoplasms 4

Interventions

Tamoxifen 4 Exercise 3 pyrotinib 2 abemaciclib 2 Paclitaxel 2 Metformin 2 Letrozole 2 Cyclophosphamide 2 Control Groups 2 Capecitabine 2 Bupivacaine 2 Aromatase Inhibitors 2 pembrolizumab 1 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 palbociclib 1 iniparib 1 exemestane 1 durvalumab 1 darolutamide 1 Yoga 1 Waiting Lists 1 Vitamin D 1 Tretinoin 1 Trastuzumab 1 Tocopherols 1 Thioctic Acid 1 Standard of Care 1 Sodium Chloride 1 Self-Help Groups 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Breast Cancer Female × palbociclib × Clear all

NCT03065621 2023-04-19

NeoRHEA

Jules Bordet Institute

Phase 2 Completed

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡